Concepedia

Héctor Luciardi

HL

16

Publications

2.3K

Citations

16

H-Index

2002

Active since

Affiliations

National University of Tucumán(Current)

Thrombosis Research Institute

University College London

Bayer (Germany)

Harvard University

Héctor Luciardi is an author at National University of Tucumán specializing in medicine, pharmacotherapy, and atherosclerosis.

Top concepts

Publications per year

2002–2022

16

Publications

16

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 855 citations · Full text

, , +13

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 749 citations · Full text

, , +12

The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?

Raúl Altman, Héctor Luciardi, Juan Muntaner et al. · Thrombosis Journal · 2004 · 114 citations · Full text

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 112 citations · Full text

Efficacy Assessment of Meloxicam, a Preferential Cyclooxygenase-2 Inhibitor, in Acute Coronary Syndromes Without ST-Segment Elevation

Raúl Altman, Héctor Luciardi, Juan Muntaner et al. · Circulation · 2002 · 109 citations · Full text

Rows per page

1–5 of 16